algestone acetophenide has been researched along with Body Weight in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammar, R; El-ganzoury, B; El-mahgoub, S; Fikri, F; Karim, M; Yaseen, S | 1 |
el-Mahgoub, S | 1 |
Abranches, AD; Barbosa, I; Coutinho, EM; de Souza, RN; Gatto, M; Hippolito, SB; Leal, C; Leal, Wde B; Morais, K; Pinho Neto, JS; Spinola, P; Tomaz, G; Yazlle, ME | 1 |
Dolman, H; Elliot, J; Levin, M; Tyler, ET | 1 |
Herzog, GM; Soule, SD | 1 |
Simmons, DJ | 1 |
1 trial(s) available for algestone acetophenide and Body Weight
Article | Year |
---|---|
Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contracep
Topics: Adolescent; Adult; Algestone Acetophenide; Body Weight; Brazil; Cohort Studies; Contraceptive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Humans; Incidence; Menstruation; Patient Acceptance of Health Care; Patient Dropouts; Progesterone Congeners; Uterine Hemorrhage | 1997 |
5 other study(ies) available for algestone acetophenide and Body Weight
Article | Year |
---|---|
Evaluation of deladroxate as a monthly contraceptive injection.
Topics: Algestone Acetophenide; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Endometrium; Ethinyl Estradiol; Family Planning Services; Injections; Liver; Menstrual Cycle; Menstruation; Ovary; Pregnancy Rate; Reproductive Control Agents | 1971 |
Body weight and cycle control of injectable contraceptives.
Topics: Adolescent; Adult; Algestone Acetophenide; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Lynestrenol; Medroxyprogesterone; Menstruation; Norethindrone; Norpregnenes; Postpartum Period; Pregnancy; Time Factors | 1980 |
Present status of injectable contraceptives: results of seven-years study.
Topics: Adolescent; Adult; Age Factors; Algestone Acetophenide; Amenorrhea; Black People; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Weight; Contraceptive Agents; Delayed-Action Preparations; Estradiol; Ethnicity; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone; Menstruation; Menstruation Disturbances; Middle Aged; Parity; Pregnancy; Pregnanes; Progestins; Prothrombin Time; White People | 1970 |
Control of fertility by monthly injection of estrogen-progestogen.
Topics: Acetophenones; Adolescent; Adult; Algestone Acetophenide; Benzene Derivatives; Body Weight; Contraceptives, Oral; Estradiol; Female; Humans; Injections, Intramuscular; Menstruation; Menstruation Disturbances; Middle Aged; Pharmaceutical Vehicles; Pregnancy; Pregnanes; Progestins; Time Factors | 1968 |
Effect of the acetophenide derivative of 16-alpha, 17-alpha-dihydroxyprogesterone and estradiol on the skeletons of rats and mice.
Topics: Algestone Acetophenide; Animals; Autoradiography; Body Weight; Bone and Bones; Bone Development; Estradiol; Femur; Growth; Mice; Microradiography; Pregnanes; Progestins; Rats; Strontium Isotopes; Thymidine; Tibia; Tritium | 1969 |